NO852776L - Derivat av humant interferon-gamma-polypeptid, rekombinant plasmid til bruk ved fremstilling derav, fremgangsmaate til fremstilling derav, og mikroorganisme inneholdende et rekombinant plasmid - Google Patents
Derivat av humant interferon-gamma-polypeptid, rekombinant plasmid til bruk ved fremstilling derav, fremgangsmaate til fremstilling derav, og mikroorganisme inneholdende et rekombinant plasmidInfo
- Publication number
- NO852776L NO852776L NO85852776A NO852776A NO852776L NO 852776 L NO852776 L NO 852776L NO 85852776 A NO85852776 A NO 85852776A NO 852776 A NO852776 A NO 852776A NO 852776 L NO852776 L NO 852776L
- Authority
- NO
- Norway
- Prior art keywords
- recombinant plasmid
- derivatives
- humant
- interferon
- preparing
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title 2
- 102000008070 Interferon-gamma Human genes 0.000 title 1
- 108010074328 Interferon-gamma Proteins 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14395084A JPS6124599A (ja) | 1984-07-11 | 1984-07-11 | 新規ヒトインタ−フエロン−ｒポリペプチド誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO852776L true NO852776L (no) | 1986-01-13 |
| NO175487B NO175487B (no) | 1994-07-11 |
| NO175487C NO175487C (no) | 1994-10-19 |
Family
ID=15350817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852776A NO175487C (no) | 1984-07-11 | 1985-07-10 | Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4898931A (no) |
| EP (1) | EP0170917B1 (no) |
| JP (1) | JPS6124599A (no) |
| AT (1) | ATE63923T1 (no) |
| AU (1) | AU586822B2 (no) |
| CA (1) | CA1303529C (no) |
| DE (2) | DE3582973D1 (no) |
| DK (1) | DK164108C (no) |
| ES (1) | ES8609484A1 (no) |
| IL (1) | IL75738A (no) |
| NO (1) | NO175487C (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334102D0 (en) * | 1983-12-21 | 1984-02-01 | Searle & Co | Interferons with cysteine pattern |
| CA1340265C (en) * | 1985-01-18 | 1998-12-15 | Kirston E. Koths | Oxidation resistant muteins |
| GB8619725D0 (en) * | 1986-08-13 | 1986-09-24 | Hoffmann La Roche | Homogenous interferon fragments |
| JP2653061B2 (ja) * | 1986-12-27 | 1997-09-10 | 武田薬品工業株式会社 | 新規ポリペプチドおよびその製造法 |
| AT393690B (de) * | 1987-10-08 | 1991-11-25 | Hoffmann La Roche | Homogene, rekombinante immun-interferonfragmente |
| DE3829180A1 (de) * | 1988-08-29 | 1990-03-08 | Boehringer Ingelheim Int | Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten |
| DE4036856C1 (no) * | 1990-11-19 | 1992-05-27 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De | |
| HUP9801746A3 (en) * | 1995-01-26 | 2000-11-28 | Biogen Idec Ma Inc Cambridge | Lymphotoxin-alfa/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| DE19535853C2 (de) * | 1995-09-18 | 1999-04-01 | Fraunhofer Ges Forschung | Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung |
| MXPA02004671A (es) | 1999-11-12 | 2004-09-10 | Maxygen Holdings Ltd | Conjugados de interferon gamma. |
| AU782635B2 (en) * | 1999-11-12 | 2005-08-18 | Maxygen Holdings Ltd. | Interferon gamma conjugates |
| US7230081B1 (en) | 1999-11-12 | 2007-06-12 | Maxygen Holdings, Ltd. | Interferon gamma conjugates |
| US7038015B2 (en) | 2001-04-06 | 2006-05-02 | Maxygen Holdings, Ltd. | Interferon gamma polypeptide variants |
| US6958388B2 (en) | 2001-04-06 | 2005-10-25 | Maxygen, Aps | Interferon gamma polypeptide variants |
| AU2003239774A1 (en) | 2002-07-03 | 2004-01-23 | Maxygen Holdings Ltd. | Full-length interferon gamma polypeptide variants |
| US8778880B2 (en) * | 2004-02-02 | 2014-07-15 | Ambrx, Inc. | Human growth hormone modified at position 35 |
| MX2007015058A (es) * | 2005-06-03 | 2008-01-28 | Ambrx Inc | Moleculas de interferon humano mejoradas y sus usos. |
| FR2898359B1 (fr) * | 2006-03-08 | 2011-07-15 | Biomethodes | Variants ameliores de l'interferon-gamma humain (ifn gamma) |
| EP1991679A2 (fr) * | 2006-03-08 | 2008-11-19 | Biomethodes | Variants de l'interferon- gamma humain (ifngamma) |
| NZ602170A (en) | 2008-02-08 | 2014-03-28 | Ambrx Inc | Modified leptin polypeptides and their uses |
| MX2021001165A (es) * | 2018-07-30 | 2021-07-15 | Univ Leland Stanford Junior | Agonistas sesgados de interferon-gamma. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU561343B2 (en) * | 1981-10-19 | 1987-05-07 | Genentech Inc. | Human immune interferon by recombinant dna |
| JPS58110548A (ja) * | 1981-12-24 | 1983-07-01 | Asahi Chem Ind Co Ltd | 新規な生理活性ペプチド |
| US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| JPH0787797B2 (ja) * | 1982-05-20 | 1995-09-27 | サントリー株式会社 | ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法 |
| US4681848A (en) * | 1982-09-22 | 1987-07-21 | Takeda Chemical Industries, Ltd. | Novel peptide and use thereof |
| IL69851A0 (en) * | 1982-09-30 | 1983-12-30 | Japan Found Cancer | Novel dna and recombinant plasmid containing the same |
| DK168016B1 (da) * | 1983-12-26 | 1994-01-17 | Kyowa Hakko Kogyo Kk | Derivat af humant interferon-gamma-polypeptid |
| AU582574B2 (en) * | 1984-04-19 | 1989-04-06 | Hoechst Aktiengesellschaft | The preparation of polypeptides having human gamma interferon activity |
| IL75302A0 (en) * | 1984-06-06 | 1985-09-29 | Takeda Chemical Industries Ltd | Novel polypeptide and production thereof |
-
1984
- 1984-07-11 JP JP14395084A patent/JPS6124599A/ja active Pending
-
1985
- 1985-07-04 CA CA000486327A patent/CA1303529C/en not_active Expired - Lifetime
- 1985-07-08 IL IL7573885A patent/IL75738A/en not_active IP Right Cessation
- 1985-07-09 EP EP85108541A patent/EP0170917B1/en not_active Expired - Lifetime
- 1985-07-09 AT AT85108541T patent/ATE63923T1/de not_active IP Right Cessation
- 1985-07-09 DE DE8585108541T patent/DE3582973D1/de not_active Expired - Lifetime
- 1985-07-09 DE DE198585108541T patent/DE170917T1/de active Pending
- 1985-07-10 AU AU44749/85A patent/AU586822B2/en not_active Ceased
- 1985-07-10 NO NO852776A patent/NO175487C/no unknown
- 1985-07-10 US US06/751,205 patent/US4898931A/en not_active Expired - Fee Related
- 1985-07-10 DK DK314485A patent/DK164108C/da not_active IP Right Cessation
- 1985-07-10 ES ES545052A patent/ES8609484A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATE63923T1 (de) | 1991-06-15 |
| ES8609484A1 (es) | 1986-09-01 |
| DE3582973D1 (de) | 1991-07-04 |
| IL75738A (en) | 1995-06-29 |
| AU586822B2 (en) | 1989-07-27 |
| EP0170917B1 (en) | 1991-05-29 |
| DK314485A (da) | 1986-01-12 |
| JPS6124599A (ja) | 1986-02-03 |
| DE170917T1 (de) | 1986-09-04 |
| NO175487B (no) | 1994-07-11 |
| NO175487C (no) | 1994-10-19 |
| ES545052A0 (es) | 1986-09-01 |
| DK164108C (da) | 1992-10-12 |
| DK164108B (da) | 1992-05-11 |
| DK314485D0 (da) | 1985-07-10 |
| CA1303529C (en) | 1992-06-16 |
| IL75738A0 (en) | 1985-11-29 |
| US4898931A (en) | 1990-02-06 |
| EP0170917A1 (en) | 1986-02-12 |
| AU4474985A (en) | 1986-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO852776L (no) | Derivat av humant interferon-gamma-polypeptid, rekombinant plasmid til bruk ved fremstilling derav, fremgangsmaate til fremstilling derav, og mikroorganisme inneholdende et rekombinant plasmid | |
| DK58789D0 (da) | Proteiner med faktor viii-aktivitet, fremgangsmaade til deres fremstilling ved anvendelse af genetisk konstruerede celler og farmaceutiske kompositioner indeholdende proteinerne | |
| CZ738982A3 (en) | Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use | |
| EP0201743A3 (en) | Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use | |
| DK16890D0 (da) | Antiviral eller antibakteriel forbindelse og frem gangsmaade til anvendelse heraf | |
| EP0151246A3 (en) | Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations | |
| DK208985A (da) | Antigent praeparat og fremgangsmaade til isolering af et saadant praeparat | |
| EP0437610A4 (en) | Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide | |
| NO883261L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| DK0402070T3 (da) | Krystallinsk r-h-GM-CSF og fremgangsmåde til fremstilling heraf | |
| LTIP610A (en) | Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds | |
| PT83952A (en) | Process for the preparation of new oxygenated-alkyl derivatives of glutamic and aspartic acids with antagonistic activity to bio-active polypeptides | |
| FI102282B1 (fi) | Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi | |
| DK695388D0 (da) | Derivater af cykliske aminosyrer, deres fremstilling og anvendelse | |
| NZ218238A (en) | Thiazolone derivatives and pharmaceutical compositions | |
| DK25779A (da) | 1-naphthyleddikesyrederivater fremgangsmaade til deres fremstilling og deres terapeutiske anvendelser | |
| DK180588A (da) | Anti-tumor-virksomme praeparater og fremgangsmaade til deres fremstilling | |
| ES8705847A1 (es) | Procedimiento para preparar nuevos derivados de n-(2-hidro- xialquil)-aminoacidos | |
| DK197091A (da) | Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater | |
| DK489086D0 (da) | Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler | |
| AU491446B2 (en) | Amino acid formulations for patients with liver disease and method of using same | |
| DK605686D0 (da) | Renset protein med angiogen aktivitet og fremgangsmaade til fremstilling deraf | |
| FI95242B (fi) | Menetelmä pyrrolijohdannaisten diesterien valmistamiseksi ja menetelmässä käyttökelpoiset välituotteet | |
| AU1024076A (en) | Amino acid formulations for patients with liver disease and method of using same | |
| RU93043610A (ru) | Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств |